BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novavax, Inc. 

9920 Belward Campus Drive

Rockville  Maryland  20850  U.S.A.
Phone: 240-268-2000 Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Delivery





 Company News
Novavax, Inc. (NVAX) Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies 10/15/2014 8:00:49 AM
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV Vaccine In Elderly Subjects 10/14/2014 8:03:36 AM
Novavax, Inc. (NVAX) Announces Biomedical Advanced Research and Development Authority (BARDA) Exercise Of Contract Option 9/23/2014 8:25:00 AM
Novavax, Inc. (NVAX)' H7n9 Avian Influenza VLP Vaccine Candidate With Matrix-M™ Delivers Positive Phase 1/2 Clinical Data 9/23/2014 8:21:47 AM
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV F-Protein Nanoparticle Vaccine Candidate In Healthy Third-Trimester Pregnant Women 9/17/2014 7:34:27 AM
Novavax, Inc. (NVAX) To Host 2nd Annual Analyst And Investor Meeting 9/12/2014 10:32:46 AM
Novavax, Inc. (NVAX) Release: ICAAC Presentation: Immunization Of Pregnant Baboons With The RSV F Nanoparticle Vaccine Protects Infant Baboons Challenged With Respiratory Syncytial Virus In A Comparable Manner To Infants Prophylaxed With Palivizumab 9/8/2014 10:13:40 AM
Novavax, Inc. (NVAX) Presents Data On RSV F Nanoparticle Vaccine Induced Monoclonal Antibody At ICAAC 9/8/2014 7:36:43 AM
Novavax, Inc. (NVAX) To Present RSV Vaccine Preclinical Results At ICAAC 9/4/2014 8:55:24 AM
Novavax, Inc. (NVAX) To Present At The Wedbush Securities Life Sciences Management Access Conference 8/8/2014 8:00:32 AM
12345678910...